| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K66532283 |
| PharmacoGx | BRD-K66532283 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DLL1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | LRRN4 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | KCNQ1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | PSKH2 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | KIF3C | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | SLC25A46 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | LAPTM5 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | PRB1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | METTL25 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | WNT10A | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
